Squamous Cell Carcinoma of the Head and Neck Treatment Market Country Level Analysis

North America leads the squamous cell carcinoma of the head and neck treatment market due to the increasing levels of investment for the development of advanced technologies such as platinum-based therapy others in this region. Asia-Pacific region, on the other hand is expected to expand at a significant growth rate because of the increasing population along with changing lifestyle and adoption of advanced technologies.